Development of Improved PPARβ/δ Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Improved PPARβ/δ Inhibitors

Published:2011-10-24 Issue:1 Volume:7 Page:159-170
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Toth Philipp M.,Naruhn Simone,Pape Veronika F. S.,Dörr Stefanie M. A.,Klebe Gerhard,Müller Rolf,Diederich Wibke E.

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference82 articles.

1. Principles for modulation of the nuclear receptor superfamily

2. The Nuclear Receptor Superfamily and Drug Discovery

3. A Unified Nomenclature System for the Nuclear Receptor Superfamily

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PPAR Ω Pocket: Renewed Opportunities for Drug Development;PPAR Research;2020-07-01

2. Investigating the Role of PPARβ/δ in Retinal Vascular Remodeling Using Pparβ/δ-Deficient Mice;International Journal of Molecular Sciences;2020-06-20

3. PPARβ/δ recruits NCOR and regulates transcription reinitiation of ANGPTL4;Nucleic Acids Research;2019-08-20

4. PPARβ/δ controls Mediator recruitment and transcription initiation;2019-01-24

5. The Role of PPARβ/δ in Melanoma Metastasis;International Journal of Molecular Sciences;2018-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3